Boing Boing

Boing Boing

Share this post

Boing Boing
Boing Boing
The first-ever patient in a Phase 3 medical study of LSD has successfully tripped balls
Copy link
Facebook
Email
Notes
More

The first-ever patient in a Phase 3 medical study of LSD has successfully tripped balls

Allan Rose Hill
Dec 16, 2024
∙ Paid
2

Share this post

Boing Boing
Boing Boing
The first-ever patient in a Phase 3 medical study of LSD has successfully tripped balls
Copy link
Facebook
Email
Notes
More
2
Share

Biopharma firm Mind Medicine announced that they have dosed the first-ever patient in a Phase 3 clinical trial of LSD. The individual tripped on lysergide D-tartrate, an LSD formulation for which the US FDA granted "breakthrough therapy" status in March as a promising treatment for generalized anxiety disorder (GAD).

Of course, Mind Medicine has patented…

Keep reading with a 7-day free trial

Subscribe to Boing Boing to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Happy Mutants LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More